SCHEMBL7148124

SCHEMBL7148124

CCCC[Si](C)(C)c1ccccc1OB(O)O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.35
NR1H3 Q13133 1/20 0.35
PCSK9 Q8NBP7 1/20 0.34
CYP1A2 P05177 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP19A1 P11511 1/20 0.33
LIPG Q9Y5X9 1/20 0.33
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
PTGS2 P35354 2/20 0.31
KDM4E B2RXH2 1/20 0.31
RECQL P46063 1/20 0.31
NR1I2 O75469 1/20 0.31
LMNA P02545 1/20 0.31
CHRM2 P08172 1/20 0.31
CYP3A4 P08684 1/20 0.31
ADRA2A P08913 1/20 0.31
MAPT P10636 1/20 0.31
OPRK1 P41145 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7284382 0.73 CNR2 (0.41) NR1H2NR1H3MEN1KMT2AMAPT
SCHEMBL3968465 0.70 LIPG (0.51) CYP2C9LIPGPTGS2CYP3A4
Pentane SCHEMBL6139807 0.70 L3MBTL1 (0.46) PCSK9CYP1A2CYP2C9CYP2C19KDM4E
SCHEMBL4849451 0.69 LIPG (0.59) LIPGPTGS2
SCHEMBL5268144 0.68 TSHR (0.36) CYP1A2MEN1KMT2AKDM4E
SCHEMBL4859494 0.68 LIPG (0.62) LIPGPTGS2
SCHEMBL4858367 0.68 LIPG (0.62) LIPGPTGS2
SCHEMBL4859387 0.68 LIPG (0.62) LIPGPTGS2
SCHEMBL716479 0.68 LIPG (0.62) LIPGPTGS2
SCHEMBL4857505 0.68 LIPG (0.62) LIPGPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1370546-A2 NOVEL AMINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS Abbott Laboratories (US) 2003-12-17 EP disclosed
WO-2002074758-A2 NOVEL AMINES AS HISTAMINE-3 RECEPTOR LIGANDS AND THEIR THERAPEUTIC APPLICATIONS ABBOTT LABORATORIES (US) 2002-09-26 WO disclosed